Literature DB >> 18212067

Homologous recombination is necessary for normal lymphocyte development.

Lura B Caddle1, Muneer G Hasham, William H Schott, Bobbi-Jo Shirley, Kevin D Mills.   

Abstract

Primary immunodeficiencies are rare but serious diseases with diverse genetic causes. Accumulating evidence suggests that defects in DNA double-strand break (DSB) repair can underlie many of these syndromes. In this context, the nonhomologous end joining pathway of DSB repair is absolutely required for lymphoid development, but possible roles for the homologous recombination (HR) pathway have remained more controversial. While recent evidence suggests that HR may indeed be important to suppress lymphoid transformation, the specific relationship of HR to normal lymphocyte development remains unclear. We have investigated roles of the X-ray cross-complementing 2 (Xrcc2) HR gene in lymphocyte development. We show that HR is critical for normal B-cell development, with Xrcc2 nullizygosity leading to p53-dependent early S-phase arrest. In the absence of p53 (encoded by Trp53), Xrcc2-null B cells can fully develop but show high rates of chromosome and chromatid fragmentation. We present a molecular model wherein Xrcc2 is important to preserve or restore replication forks during rapid clonal expansion of developing lymphocytes. Our findings demonstrate a key role for HR in lymphoid development and suggest that Xrcc2 defects could underlie some human primary immunodeficiencies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212067      PMCID: PMC2268416          DOI: 10.1128/MCB.02139-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice.

Authors:  B Deans; C S Griffin; M Maconochie; J Thacker
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation.

Authors:  J E Sale; D M Calandrini; M Takata; S Takeda; M S Neuberger
Journal:  Nature       Date:  2001-08-30       Impact factor: 49.962

3.  Identification and purification of two distinct complexes containing the five RAD51 paralogs.

Authors:  J Y Masson; M C Tarsounas; A Z Stasiak; A Stasiak; R Shah; M J McIlwraith; F E Benson; S C West
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 4.  The mechanism and regulation of chromosomal V(D)J recombination.

Authors:  Craig H Bassing; Wojciech Swat; Frederick W Alt
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 5.  Histone H2A variants H2AX and H2AZ.

Authors:  Christophe Redon; Duane Pilch; Emmy Rogakou; Olga Sedelnikova; Kenneth Newrock; William Bonner
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

Review 6.  Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies.

Authors:  Anna Villa; Christina Sobacchi; Paulo Vezzoni
Journal:  Isr Med Assoc J       Date:  2002-03       Impact factor: 0.892

7.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

Authors:  T T Paull; E P Rogakou; V Yamazaki; C U Kirchgessner; M Gellert; W M Bonner
Journal:  Curr Biol       Date:  2000 Jul 27-Aug 10       Impact factor: 10.834

8.  Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs.

Authors:  M Takata; M S Sasaki; S Tachiiri; T Fukushima; E Sonoda; D Schild; L H Thompson; S Takeda
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 9.  Deconstructing common variable immunodeficiency by genetic analysis.

Authors:  Alejandro A Schäffer; Ulrich Salzer; Lennart Hammarström; Bodo Grimbacher
Journal:  Curr Opin Genet Dev       Date:  2007-04-27       Impact factor: 5.578

Review 10.  Genetic defects in common variable immunodeficiency.

Authors:  O Kopecký; S Lukesová
Journal:  Int J Immunogenet       Date:  2007-08       Impact factor: 1.466

View more
  10 in total

1.  Activation-induced cytidine deaminase-initiated off-target DNA breaks are detected and resolved during S phase.

Authors:  Muneer G Hasham; Kathy J Snow; Nina M Donghia; Jane A Branca; Mark D Lessard; Janet Stavnezer; Lindsay S Shopland; Kevin D Mills
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

2.  Chromosomal translocations caused by either pol32-dependent or pol32-independent triparental break-induced replication.

Authors:  José F Ruiz; Belén Gómez-González; Andrés Aguilera
Journal:  Mol Cell Biol       Date:  2009-08-03       Impact factor: 4.272

3.  Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination.

Authors:  Muneer G Hasham; Nina M Donghia; Eliot Coffey; Jane Maynard; Kathy J Snow; Jacquelyn Ames; Robert Y Wilpan; Yishu He; Benjamin L King; Kevin D Mills
Journal:  Nat Immunol       Date:  2010-07-25       Impact factor: 25.606

4.  The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis.

Authors:  Juliane Braun; Arabella Meixner; Andreas Brachner; Roland Foisner
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

5.  RECQ helicases are deregulated in hematological malignancies in association with a prognostic value.

Authors:  Elena Viziteu; Alboukadel Kassambara; Philippe Pasero; Bernard Klein; Jerome Moreaux
Journal:  Biomark Res       Date:  2016-02-13

6.  Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Authors:  Teresa Amaral; Martin Schulze; Tobias Sinnberg; Maike Nieser; Peter Martus; Florian Battke; Claus Garbe; Saskia Biskup; Andrea Forschner
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

7.  Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients.

Authors:  Parisa Amirifar; Mahya Mehrmohamadi; Mohammad Reza Ranjouri; Seyed Mohammad Akrami; Nima Rezaei; Ali Saberi; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2021-10-10       Impact factor: 8.542

8.  Attenuating homologous recombination stimulates an AID-induced antileukemic effect.

Authors:  Kristin R Lamont; Muneer G Hasham; Nina M Donghia; Jane Branca; Margaret Chavaree; Betsy Chase; Anne Breggia; Jacquelyn Hedlund; Ivette Emery; Francesca Cavallo; Maria Jasin; Jens Rüter; Kevin D Mills
Journal:  J Exp Med       Date:  2013-05-06       Impact factor: 14.307

9.  Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease.

Authors:  Saskia N van der Crabben; Marije P Hennus; Grant A McGregor; Deborah I Ritter; Sandesh C S Nagamani; Owen S Wells; Magdalena Harakalova; Ivan K Chinn; Aaron Alt; Lucie Vondrova; Ron Hochstenbach; Joris M van Montfrans; Suzanne W Terheggen-Lagro; Stef van Lieshout; Markus J van Roosmalen; Ivo Renkens; Karen Duran; Isaac J Nijman; Wigard P Kloosterman; Eric Hennekam; Jordan S Orange; Peter M van Hasselt; David A Wheeler; Jan J Palecek; Alan R Lehmann; Antony W Oliver; Laurence H Pearl; Sharon E Plon; Johanne M Murray; Gijs van Haaften
Journal:  J Clin Invest       Date:  2016-07-18       Impact factor: 14.808

10.  Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition.

Authors:  John J Wilson; Kin-Hoe Chow; Nathan J Labrie; Jane A Branca; Thomas J Sproule; Bryant R A Perkins; Elise E Wolf; Mauro Costa; Grace Stafford; Christine Rosales; Kevin D Mills; Derry C Roopenian; Muneer G Hasham
Journal:  Cancer Biol Ther       Date:  2018-09-05       Impact factor: 4.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.